FORMULATION ARTICLES

coronavirus covid-GettyImages-1220020527 FDA Sets Recommendations For Predicting Dangerous Nitrosamine Impurities

The FDA recently published a final guidance that sets a recommended framework for predicting the potential of nitrosamine drug substance-related impurities.

FORMULATION VIDEOS

How PCR-based technology can accelerate mRNA development and manufacturing and design principles/critical parameters to enable the rapid development of lipids for RNA formulation.

In this video, Russell Johnson, VP Formulation Research for RVAC Medicines, and Aalok Shah, Director of Formulation & Drug Delivery, Strand Therapeutics, share their thoughts on the scientific-research and CMC-related reasons that have made the lipid nanoparticle the “darling” of the delivery world for mRNA/RNA products today.

Explore the new capacity of our complete mRNA Ecosystem that offers a streamline service to develop, product, and release of both mRNA drug substance and drug product.

Russell Johnson, VP Formulation Research for RVAC Medicines, and Aalok Shah, Director of Formulation & Drug Delivery, Strand Therapeutics, share their expectations on which scientific advancements/characteristics will be most important for LNP-delivery of mRNA/RNA cargo in the future.

FORMULATION RESOURCES